Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Wahl

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Journal Des Maladies Vasculaires|August 23, 2015
[Vascular medicine of the future]Denis Wahl
Blood|May 12, 2018
"Antiphospholipids": the more, the worse?Denis Wahl
British Journal of Haematology|January 22, 2020
Antiphospholipid syndrome and direct oral anticoagulants: to the future and back again?Denis Wahl
Annals of Internal Medicine|October 15, 2019
Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?Denis Wahl, Virginie Dufrost
JAMA|July 6, 2006
Treatment of antiphospholipid antibody syndromeDenis Wahl, Veronique Regnault
Current Rheumatology Reports|January 22, 2015
Pulmonary hypertension in antiphospholipid syndromeStéphane Zuily, Denis Wahl
Rheumatology (Oxford, England)|February 6, 2024
Viewpoint: Provoked thrombosis in antiphospholipid syndromeDenis Wahl, Vittorio Pengo
JAMA|June 16, 2005
Cost-effectiveness of ximelagatran for stroke preventionChristine Perret-Guillaume, Denis Wahl
The New England Journal of Medicine|October 16, 2014
Inhibition of the mTORC pathway in the antiphospholipid syndromeStéphane Zuily, Véronique Regnault, Denis Wahl
Arthritis and Rheumatism|February 2, 2008
Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et alDenis Wahl, Thomas Lecompte, Henri Bounameaux
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Journal Des Maladies Vasculaires|August 23, 2015
[Vascular medicine of the future]Denis Wahl
Blood|May 12, 2018
"Antiphospholipids": the more, the worse?Denis Wahl
British Journal of Haematology|January 22, 2020
Antiphospholipid syndrome and direct oral anticoagulants: to the future and back again?Denis Wahl
Annals of Internal Medicine|October 15, 2019
Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?Denis Wahl, Virginie Dufrost
JAMA|July 6, 2006
Treatment of antiphospholipid antibody syndromeDenis Wahl, Veronique Regnault
Current Rheumatology Reports|January 22, 2015
Pulmonary hypertension in antiphospholipid syndromeStéphane Zuily, Denis Wahl
Rheumatology (Oxford, England)|February 6, 2024
Viewpoint: Provoked thrombosis in antiphospholipid syndromeDenis Wahl, Vittorio Pengo
JAMA|June 16, 2005
Cost-effectiveness of ximelagatran for stroke preventionChristine Perret-Guillaume, Denis Wahl
The New England Journal of Medicine|October 16, 2014
Inhibition of the mTORC pathway in the antiphospholipid syndromeStéphane Zuily, Véronique Regnault, Denis Wahl
Arthritis and Rheumatism|February 2, 2008
Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et alDenis Wahl, Thomas Lecompte, Henri Bounameaux
Pageof 14